Konica Minolta (4902) Q4 2025 earnings summary

Executive summary

• FY2024 revenue rose 2% year-over-year to ¥1,127.9B, mainly due to favorable FOREX and growth in Digital Workplace, Professional Print, and Imaging Solutions, while Industry Business declined.

• Operating loss of ¥64.0B (down ¥91.5B from prior year profit), mainly due to one-time impairment losses, restructuring costs, and business transfers.

• Loss attributable to owners was ¥47.5B, compared to a profit last year, impacted by discontinued operations and significant impairments.

• Precision Medicine Business was classified as discontinued and divested; gain from Ambry Genetics sale contributed ¥45.0B to discontinued operations.

• Major management reforms, business selection/concentration, and global structural reforms executed as planned.

Financial highlights

• Gross profit increased 1% year-over-year to ¥479.4B, but gross margin declined by 0.4pt to 42.5%.

• Business contribution profit decreased 4% to ¥31.9B; operating profit swung from ¥27.5B to a ¥64.0B loss.

• Free cash flow improved to ¥75.7B (up 95%), with operating cash flow at ¥51.0B and investing cash flow at ¥24.6B.

• EPS dropped from ¥9.15 to ¥-95.98; ROE fell to -9.5%.

• Significant impairment losses of ¥51.1B and business structure improvement expenses of ¥21.6B were recorded.

Outlook and guidance

• FY2025/2026 revenue is forecast to decline to ¥1,050.0B due to business selection, concentration, and FOREX impact.

• Business contribution profit is projected to rise to ¥52.5B, operating profit to ¥48.0B, and profit attributable to owners to recover to ¥24.0B.

• Dividend forecast set at ¥10 per share; ROE target at 5%.

• US reciprocal tariffs may impact revenue by ¥16.0B, with mitigation planned via cost reduction and supply chain adjustments.

• Management expects continued uncertainty from economic slowdown, price increases, and FX volatility, but aims for profit growth via reforms.